CTI Biopharma's cancer drug fails late-stage trial

CTI Biopharma Corp said on Monday its treatment for a type of blood cancer did not meet the main goal of a late-stage trial.

from Reuters: Health News https://ift.tt/2MV7XmQ
via IFTTT